title: Comment on: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".
authors.affiliation: Frankfurt School of Finance and Management, Frankfurt, Germany, a.gandjour@fs.de.
authors.forename: Afschin
authors.initials: A
authors.lastname: Gandjour
mesh_terms: D006801:Humans; D032541:Mass Vaccination / Q000191:economics*; D014612:Vaccines / Q000191:economics*
chemical_list: D014612:Vaccines